Rexahn Pharmaceuticals Inc.

(RNN)

By |

Profile

Rexahn Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is dedicated to the discovery, development, and commercialization of treatments for cancer. Its mission is to improve the lives of cancer patients by developing next-generation cancer therapies that are designed to maximize efficacy while minimizing the toxicity and side effects traditionally associated with cancer treatment. Rexahn has developed three clinical-stage drug candidates: RX-3117, Supinoxin (RX-5902) and Archexin. RX-3117 is a small molecule nucleoside compound with an anti-metabolite mechanism of action.

Contact Information

Website: www.rexahn.com
Email: info@rexahn.com
Main Phone: +1 240 268-5300
Address: 15245 Shady Grove Road
Address 2: Suite 455
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: AMX
CEO: Douglas J. Swirsky
Employees: 17
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.02 $ -0.01 (-0.97%)
Last Price 1.02 Change $ -0.01 Change % -0.97 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 1.03 High 1.04 Low 1.00 Prev Close 1.03
Last Trade Volume 179,047 52 Wk Hi 2.70 52 Wk Low 1.00
Market Cap 38.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,521,170.00 EPS (TTM) -0.45 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 4
Number of Buys 0 4
Number of Sells 0 0
Net Activity 0 20250
Last 10 Buys Shares
Richard Kivel 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Peter C. Brandt 1,000
Last 10 Sell Shares
Chang Ho Ahn 1,000
Chang Ho Ahn 1,000
Tae Heum Jeong 1,000
Chang Ho Ahn 1,000
Tae Heum Jeong 1,000
Chang Ho Ahn 1,000
Tae Heum Jeong 1,000
Chang Ho Ahn 1,000
Tae Heum Jeong 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 19.5 19.5 19.5 19.5
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 16.25 16.25 16.25 16.25
Standard Deviation 4.6 4.6 4.6 4.6
Date of Most Recent Estimate 03/12/18 03/12/18 03/12/18 03/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.33 1.33